e.g., HRA000087; HRA000150
  1. Home
  2. Browse
  3. HRA000998
HRA000998
   HRA000998.xlsx
Title:
Research and development of accurate and real-time evaluation technology for novel proton heavy ion radiotherapy system
Release date:
2023-05-31
Description:
Research Objectives: 1. Develop a new mobile, online dual-mode PET/CT Particle Radiotherapy guidance equipment, and establish the guidance evaluation system in Particle Radiotherapy; 2. To establish the key technology of multi-dimensional, such as functional imaging, multi-omics, detection to calibrate the differences in particle radiation effects between individuals of prostate cancer.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA005258
Study type:
Disease Study
Disease name:
prostate cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000554
DAC name:
miRNA data
Contact person:
Yu Qi
Email:
yuphar@126.com
Description:
Detection of plasma miRNA in prostate cancer before and after radiotherapy
Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
HRI133374P1-1maleHRS2594831_R1Carbon ion radiotherapy for prostate cancer
HRI133375P1-2maleHRS2594842_R1Carbon ion radiotherapy for prostate cancer
HRI133376P2-1maleHRS2594855_R1Carbon ion radiotherapy for prostate cancer
HRI133377P2-2maleHRS2594866_R1Carbon ion radiotherapy for prostate cancer
HRI133378P3-1maleHRS2594877_R1Carbon ion radiotherapy for prostate cancer
HRI133379P3-2maleHRS2594888_R1Carbon ion radiotherapy for prostate cancer
HRI133380P4-1maleHRS2594899_R1Carbon ion radiotherapy for prostate cancer
HRI133381P4-2maleHRS25949010_R1Carbon ion radiotherapy for prostate cancer
HRI133382P5-1maleHRS25949111_R1Carbon ion radiotherapy for prostate cancer
HRI133383P5-2maleHRS25949212_R1Carbon ion radiotherapy for prostate cancer
Showing 1 to 10 of 16 rows rows per page
Files
Request Data
Run accession
Files
Experiment
Experiment title
Platform
Sample
Run accession
Files
Experiment
Experiment title
Platform
Sample
HRR328063HRR328063.fastq.gz (0.26 GB)HRX281840High-throughput sequencing of P1-1Illumina HiSeq 2500HRS259483 (SAMC1684406)
HRR328064HRR328064.fastq.gz (0.22 GB)HRX281841High-throughput sequencing of P1-2Illumina HiSeq 2500HRS259484 (SAMC1684408)
HRR328065HRR328065.fastq.gz (0.21 GB)HRX281842High-throughput sequencing of P2-1Illumina HiSeq 2500HRS259485 (SAMC1684412)
HRR328066HRR328066.fastq.gz (0.26 GB)HRX281843High-throughput sequencing of P2-2Illumina HiSeq 2500HRS259486 (SAMC1684415)
HRR328067HRR328067.fastq.gz (0.31 GB)HRX281844High-throughput sequencing of P3-1Illumina HiSeq 2500HRS259487 (SAMC1684418)
HRR328068HRR328068.fastq.gz (0.26 GB)HRX281845High-throughput sequencing of P3-2Illumina HiSeq 2500HRS259488 (SAMC1684422)
HRR328069HRR328069.fastq.gz (0.23 GB)HRX281846High-throughput sequencing of P4-1Illumina HiSeq 2500HRS259489 (SAMC1684426)
HRR328070HRR328070.fastq.gz (0.31 GB)HRX281847High-throughput sequencing of P4-2Illumina HiSeq 2500HRS259490 (SAMC1684428)
HRR328071HRR328071.fastq.gz (0.28 GB)HRX281848High-throughput sequencing of P5-1Illumina HiSeq 2500HRS259491 (SAMC1684431)
HRR328072HRR328072.fastq.gz (0.25 GB)HRX281849High-throughput sequencing of P5-2Illumina HiSeq 2500HRS259492 (SAMC1684434)
Showing 1 to 10 of 16 rows rows per page
Submitter:   Yu Qi / yuphar@126.com
Organization:   Fudan University Shanghai Cancer Center
Submission date:   2021-05-31
Requests:   -